empagliflozin

Term ID

CHEBI:82720

Synonyms

(1S)-1,5-anhydro-1-(4-chloro-3-{4-[(3S)-tetrahydrofuran-3-yloxy]benzyl}phenyl)-D-glucitol
(1S)-1,5-anhydro-1-C-{4-chloro-3-((4-{((3S)-oxolan-3-yl)oxy}phenyl)methyl)phenyl}-D-glucitol
1-chloro-4-(glucopyranos-1-yl)-2-(4-(tetrahydrofuran-3-yloxy)benzyl)benzene
BI 10773
BI-10773
BI10773
empagliflozin
JARDIANCE

Definition

A C-glycosyl compound consisting of a β-glucosyl residue having a (4-chloro-3-{4-[(3S)-tetrahydrofuran-3-yloxy]benzyl}phenyl group at the anomeric centre. A sodium-glucose co-transporter 2 inhibitor used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

References

cas:864070-44-0
drugcentral:4830
kegg.drug:D10459
pubmed:23859488
pubmed:23859534
pubmed:23906415
pubmed:24226524
pubmed:24491572
pubmed:24716752
pubmed:24722494
pubmed:24746173
pubmed:24766495
pubmed:24795251
pubmed:24929430
pubmed:24944269
pubmed:24948511
pubmed:24958326
pubmed:24964723
pubmed:24991224
pubmed:24993361
pubmed:25061325
pubmed:25161155
pubmed:25199997
pubmed:25260362
pubmed:25271206
pubmed:25274537
pubmed:25296258
pubmed:25301180
reaxys:12378768
wikipedia.en:Empagliflozin

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from empagliflozin

Phenotype where environments contain empagliflozin

Phenotype modified by environments containing empagliflozin

Phenotype affecting empagliflozin

Human Disease Model